Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | yes | yes: 3 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q5S8
PDB structure(s): 2wsa_A , 3h5z_A , 4a2z_A , 4a30_A , 4a31_A , 4a32_A , 4a33_A , 4c7h_A , 4c7i_A , 4cgl_A , 4cgm_A , 4cgn_A , 4cgo_A , 4cgp_A , 4cyn_A , 4cyo_A , 4cyp_A , 4cyq_A , 4ucm_A , 4ucn_A , 4ucp_A , 5a27_A , 5a28_A , 5ag4_A , 5ag5_A , 5ag6_A , 5ag7_A , 5age_A , 5g20_A , 5g21_A , 6eu5_A , 6ewf_A , 6gnh_A , 6gns_A , 6gnt_A , 6gnu_A , 6gnv_A , 6qd9_A , 6qda_A , 6qdb_A , 6qdc_A , 6qdd_A , 6qde_A , 6qdf_A , 6qdg_A , 6qdh_A , 6tw7_AAA , 6tw8_AAA , 6tw8_CCC
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 12 |
GO:0006498 | N-terminal protein lipidation | 6 | 12 |
GO:0006499 | N-terminal protein myristoylation | 7 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0018008 | N-terminal peptidyl-glycine N-myristoylation | 7 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018201 | peptidyl-glycine modification | 6 | 2 |
GO:0018377 | protein myristoylation | 6 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0031365 | N-terminal protein amino acid modification | 5 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0043543 | protein acylation | 5 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity | 6 | 12 |
GO:0016410 | N-acyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016746 | acyltransferase activity | 3 | 12 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 12 |
GO:0019107 | myristoyltransferase activity | 5 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 379 | 383 | PF00656 | 0.454 |
CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.788 |
CLV_MEL_PAP_1 | 228 | 234 | PF00089 | 0.426 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.388 |
CLV_NRD_NRD_1 | 276 | 278 | PF00675 | 0.459 |
CLV_PCSK_FUR_1 | 176 | 180 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.398 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.357 |
CLV_PCSK_KEX2_1 | 250 | 252 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 276 | 278 | PF00082 | 0.462 |
CLV_PCSK_PC1ET2_1 | 178 | 180 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 250 | 252 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 265 | 269 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 276 | 280 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 317 | 321 | PF00082 | 0.419 |
CLV_Separin_Metazoa | 74 | 78 | PF03568 | 0.346 |
DEG_SCF_FBW7_1 | 207 | 214 | PF00400 | 0.385 |
DOC_CKS1_1 | 135 | 140 | PF01111 | 0.385 |
DOC_CKS1_1 | 208 | 213 | PF01111 | 0.369 |
DOC_CKS1_1 | 58 | 63 | PF01111 | 0.433 |
DOC_MAPK_DCC_7 | 176 | 185 | PF00069 | 0.385 |
DOC_MAPK_gen_1 | 115 | 125 | PF00069 | 0.371 |
DOC_MAPK_gen_1 | 176 | 185 | PF00069 | 0.394 |
DOC_MAPK_gen_1 | 410 | 418 | PF00069 | 0.553 |
DOC_MAPK_MEF2A_6 | 412 | 420 | PF00069 | 0.541 |
DOC_PP1_RVXF_1 | 119 | 126 | PF00149 | 0.516 |
DOC_PP1_RVXF_1 | 27 | 33 | PF00149 | 0.615 |
DOC_PP2B_LxvP_1 | 101 | 104 | PF13499 | 0.369 |
DOC_PP4_FxxP_1 | 242 | 245 | PF00568 | 0.363 |
DOC_PP4_FxxP_1 | 32 | 35 | PF00568 | 0.589 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 259 | 263 | PF00917 | 0.469 |
DOC_USP7_MATH_1 | 350 | 354 | PF00917 | 0.426 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.828 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.397 |
DOC_USP7_UBL2_3 | 117 | 121 | PF12436 | 0.516 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.469 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.385 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.356 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.367 |
LIG_14-3-3_CanoR_1 | 327 | 333 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 89 | 99 | PF00244 | 0.404 |
LIG_Actin_WH2_2 | 119 | 136 | PF00022 | 0.516 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.765 |
LIG_BRCT_BRCA1_1 | 368 | 372 | PF00533 | 0.454 |
LIG_BRCT_BRCA1_1 | 92 | 96 | PF00533 | 0.385 |
LIG_CSL_BTD_1 | 58 | 61 | PF09270 | 0.369 |
LIG_EH1_1 | 371 | 379 | PF00400 | 0.506 |
LIG_eIF4E_1 | 202 | 208 | PF01652 | 0.404 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.482 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.369 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.369 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.585 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.454 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.611 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.404 |
LIG_LIR_Apic_2 | 298 | 303 | PF02991 | 0.438 |
LIG_LIR_Apic_2 | 324 | 329 | PF02991 | 0.369 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 137 | 145 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 165 | 175 | PF02991 | 0.369 |
LIG_LIR_Gen_1 | 195 | 206 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 336 | 346 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 195 | 201 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 229 | 235 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 320 | 326 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 336 | 341 | PF02991 | 0.369 |
LIG_LYPXL_yS_3 | 408 | 411 | PF13949 | 0.369 |
LIG_PDZ_Class_2 | 416 | 421 | PF00595 | 0.402 |
LIG_Pex14_1 | 198 | 202 | PF04695 | 0.369 |
LIG_PTAP_UEV_1 | 255 | 260 | PF05743 | 0.400 |
LIG_PTB_Apo_2 | 332 | 339 | PF02174 | 0.391 |
LIG_PTB_Apo_2 | 380 | 387 | PF02174 | 0.381 |
LIG_PTB_Apo_2 | 402 | 409 | PF02174 | 0.369 |
LIG_PTB_Phospho_1 | 332 | 338 | PF10480 | 0.391 |
LIG_PTB_Phospho_1 | 339 | 345 | PF10480 | 0.376 |
LIG_PTB_Phospho_1 | 402 | 408 | PF10480 | 0.369 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.438 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.441 |
LIG_SH2_CRK | 326 | 330 | PF00017 | 0.410 |
LIG_SH2_CRK | 338 | 342 | PF00017 | 0.337 |
LIG_SH2_SRC | 157 | 160 | PF00017 | 0.327 |
LIG_SH2_SRC | 282 | 285 | PF00017 | 0.283 |
LIG_SH2_STAP1 | 92 | 96 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 300 | 303 | PF00017 | 0.234 |
LIG_SH2_STAT5 | 311 | 314 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 345 | 348 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 402 | 405 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.369 |
LIG_SH3_1 | 253 | 259 | PF00018 | 0.404 |
LIG_SH3_3 | 203 | 209 | PF00018 | 0.500 |
LIG_SH3_3 | 253 | 259 | PF00018 | 0.373 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.385 |
LIG_SUMO_SIM_anti_2 | 362 | 367 | PF11976 | 0.390 |
LIG_SUMO_SIM_anti_2 | 414 | 420 | PF11976 | 0.517 |
LIG_SUMO_SIM_par_1 | 181 | 187 | PF11976 | 0.369 |
LIG_SUMO_SIM_par_1 | 376 | 382 | PF11976 | 0.426 |
LIG_SxIP_EBH_1 | 231 | 241 | PF03271 | 0.430 |
LIG_WRC_WIRS_1 | 283 | 288 | PF05994 | 0.417 |
LIG_WRC_WIRS_1 | 322 | 327 | PF05994 | 0.369 |
LIG_WW_1 | 103 | 106 | PF00397 | 0.369 |
MOD_CDK_SPK_2 | 134 | 139 | PF00069 | 0.404 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.608 |
MOD_CK2_1 | 290 | 296 | PF00069 | 0.429 |
MOD_CK2_1 | 382 | 388 | PF00069 | 0.454 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.403 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.525 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.417 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.472 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.467 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.569 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.367 |
MOD_GSK3_1 | 317 | 324 | PF00069 | 0.368 |
MOD_N-GLC_1 | 192 | 197 | PF02516 | 0.461 |
MOD_N-GLC_1 | 382 | 387 | PF02516 | 0.431 |
MOD_N-GLC_1 | 90 | 95 | PF02516 | 0.385 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.494 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.432 |
MOD_PIKK_1 | 14 | 20 | PF00454 | 0.482 |
MOD_PIKK_1 | 411 | 417 | PF00454 | 0.475 |
MOD_PKA_1 | 317 | 323 | PF00069 | 0.454 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.426 |
MOD_Plk_1 | 295 | 301 | PF00069 | 0.522 |
MOD_Plk_1 | 382 | 388 | PF00069 | 0.516 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.450 |
MOD_Plk_2-3 | 38 | 44 | PF00069 | 0.438 |
MOD_Plk_2-3 | 382 | 388 | PF00069 | 0.490 |
MOD_Plk_4 | 328 | 334 | PF00069 | 0.365 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.361 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.385 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.356 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.367 |
MOD_SUMO_rev_2 | 262 | 270 | PF00179 | 0.500 |
MOD_SUMO_rev_2 | 314 | 320 | PF00179 | 0.516 |
MOD_SUMO_rev_2 | 37 | 42 | PF00179 | 0.498 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 338 | 341 | PF00928 | 0.404 |
TRG_ENDOCYTIC_2 | 408 | 411 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 114 | 116 | PF00400 | 0.385 |
TRG_ER_diArg_1 | 190 | 192 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 275 | 277 | PF00400 | 0.490 |
TRG_Pf-PMV_PEXEL_1 | 161 | 165 | PF00026 | 0.396 |
TRG_Pf-PMV_PEXEL_1 | 173 | 177 | PF00026 | 0.362 |
TRG_Pf-PMV_PEXEL_1 | 220 | 225 | PF00026 | 0.435 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8K2 | Leptomonas seymouri | 78% | 100% |
A0A0S4JHM4 | Bodo saltans | 60% | 100% |
A0A1X0P7N7 | Trypanosomatidae | 59% | 92% |
A0A3R7MKK1 | Trypanosoma rangeli | 55% | 94% |
A0A3S5H7R0 | Leishmania donovani | 98% | 100% |
A4HJY8 | Leishmania braziliensis | 91% | 100% |
A4I7H1 | Leishmania infantum | 98% | 100% |
A7YT82 | Danio rerio | 43% | 86% |
D0A003 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 94% |
E9B2C8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
O43010 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 42% | 90% |
O60551 | Homo sapiens | 44% | 85% |
O61613 | Drosophila melanogaster | 41% | 89% |
O70310 | Mus musculus | 42% | 85% |
O70311 | Mus musculus | 45% | 80% |
O74234 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 41% | 93% |
P0CP20 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 43% | 85% |
P0CP21 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 43% | 85% |
P14743 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 41% | 93% |
P30418 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 43% | 93% |
P30419 | Homo sapiens | 42% | 85% |
P31717 | Bos taurus | 42% | 85% |
P34763 | Ajellomyces capsulatus | 40% | 80% |
P34809 | Cryptococcus neoformans | 44% | 86% |
P46548 | Caenorhabditis elegans | 43% | 94% |
Q4I061 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 40% | 75% |
Q553B6 | Dictyostelium discoideum | 44% | 100% |
Q5RAF3 | Pongo abelii | 42% | 85% |
Q5UR64 | Acanthamoeba polyphaga mimivirus | 26% | 100% |
Q6BJF4 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 43% | 93% |
Q6C7G2 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 41% | 95% |
Q6CMK4 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 40% | 94% |
Q75EK2 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 40% | 93% |
Q7S3C8 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 41% | 74% |
Q8ILW6 | Plasmodium falciparum (isolate 3D7) | 40% | 100% |
Q8K1Q0 | Rattus norvegicus | 42% | 85% |
Q8TFN1 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 41% | 85% |
Q94L32 | Arabidopsis thaliana | 38% | 98% |
Q9LTR9 | Arabidopsis thaliana | 47% | 97% |
Q9N181 | Bos taurus | 44% | 85% |
Q9U419 | Plasmodium falciparum | 40% | 100% |
Q9UVX3 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 40% | 86% |
V5DTE0 | Trypanosoma cruzi | 56% | 93% |